Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety.

[1]  T. Le,et al.  Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain , 2009, BMC neurology.

[2]  H. Buschman,et al.  Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy. , 2009, Journal of diabetes and its complications.

[3]  P. House.  The Effects of Spinal Cord Stimulation in Neuropathic Pain Are Sustained: A 24-Month Follow-up of the Prospective Randomized Controlled Multicenter Trial of the Effectiveness of Spinal Cord Stimulation , 2009 .

[4]  David Cella,et al.  Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. , 2008, The journal of pain : official journal of the American Pain Society.

[5]  M. van Kleef,et al.  Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. , 2008, Journal of neurosurgery.

[6]  E. Buchser,et al.  Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome , 2007, Pain.

[7]  J. Wernicke,et al.  An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain. , 2007, Pain medicine.

[8]  D. Zochodne.  Diabetes mellitus and the peripheral nervous system: Manifestations and mechanisms , 2007, Muscle & nerve.

[9]  M. Rowbotham,et al.  Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. , 2007, Clinical therapeutics.

[10]  J. Wernicke,et al.  A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain , 2006, Neurology.

[11]  D. Goldstein,et al.  Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. , 2006, Pain medicine.

[12]  T. Jensen,et al.  New perspectives on the management of diabetic peripheral neuropathic pain , 2006, Diabetes & vascular disease research.

[13]  C. Daousi,et al.  The natural history of chronic painful peripheral neuropathy in a community diabetes population , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[14]  W. Cayley.  Antidepressants for the treatment of neuropathic pain. , 2006, American family physician.

[15]  Smriti Iyengar,et al.  Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. , 2006, Journal of palliative medicine.

[16]  B. Stacey,et al.  Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. , 2005, The journal of pain : official journal of the American Pain Society.

[17]  G. Guyatt,et al.  Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.

[18]  S. Dogra,et al.  Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo‐controlled study , 2005, European journal of pain.

[19]  M. Detke,et al.  Duloxetine vs. placebo in patients with painful diabetic neuropathy , 2005, Pain.

[20]  C. Daousi,et al.  Electrical spinal cord stimulation in the long‐term treatment of chronic painful diabetic neuropathy , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[21]  D. Selvarajah,et al.  Morphine, gabapentin, or their combination for neuropathic pain. , 2005, The New England journal of medicine.

[22]  R. Poole,et al.  Pregabalin relieves symptoms of painful diabetic neuropathy , 2004, Neurology.

[23]  T. Nurmikko,et al.  Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[24]  J. Rosenstock,et al.  Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial , 2004, Pain.

[25]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[26]  M. van Kleef,et al.  The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: Two years' follow‐up of the randomized controlled trial , 2004, Annals of neurology.

[27]  N. Harris,et al.  Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography , 1993, Diabetologia.

[28]  D. Greene,et al.  Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat , 1993, Diabetologia.

[29]  A. Gordon,et al.  Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy , 2003, Pain.

[30]  R. Portenoy,et al.  Controlled-release oxycodone for pain in diabetic neuropathy , 2003, Neurology.

[31]  E. Davidson,et al.  Preventing Superoxide Formation in Epineurial Arterioles of the Sciatic Nerve from Diabetic Rats Restores Endothelium-dependent Vasodilation , 2003, Free radical research.

[32]  Sharon M. Watanabe.  Lamotrigine reduces painful diabetic neuropathy : a randomized , controlled study , 2003 .

[33]  A. Boulton,et al.  The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[34]  Paul J Thornalley.  Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. , 2002, International review of neurobiology.

[35]  H C de Vet,et al.  Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. , 2000, The New England journal of medicine.

[36]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[37]  S. Geerlings,et al.  Immune dysfunction in patients with diabetes mellitus (DM). , 1999, FEMS immunology and medical microbiology.

[38]  A. Beydoun,et al.  Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial , 1999 .

[39]  S. Basili,et al.  Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. , 1997, Metabolism: clinical and experimental.

[40]  S. Tesfaye,et al.  Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy , 1996, The Lancet.

[41]  R. Nath,et al.  Spinal cord stimulation for chronic pain in peripheral neuropathy. , 1996, Surgical neurology.

[42]  F. A. Gries,et al.  The Epidemiology of Diabetic Neuropathy , 1993 .

[43]  M. Spüler,et al.  The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. , 1992, Journal of diabetes and its complications.

[44]  H. Beck-Nielsen,et al.  Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. , 1990, British journal of clinical pharmacology.

[45]  K. Brøsen,et al.  The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms , 1990, Pain.

[46]  A. Wilson,et al.  Sural nerve oxygen tension in diabetes. , 1986, British medical journal.

[47]  A. Boulton,et al.  Continuous Subcutaneous Insulin Infusion in the Management of Painful Diabetic Neuropathy , 1982, Diabetes Care.